16-19 June 2025 BIO International Convention 2025 Boston Convention & Exhibition Center, Boston MA United States
8 May 2025 ORYZON awarded 13.26 million € through the first Important Project of Common European Interest (IPCEI) in the health sector (Med4Cure project)
15 April 2025 ORYZON announces first patient dosed in NCI-sponsored Phase I/II clinical trial of iadademstat plus immune checkpoint inhibitors in 1L extensive stage Small Cell Lung Cancer